The high cost of sickle cell gene therapies is pushing private insurers and Medicaid programs to develop new payment models.

Nearly a year after new sickle cell gene therapies were approved, CNBC's Bertha Coombs reports a small number of patients are ...

The Philadelphia Citizen is recognizing CHOP doctors Alexis Thompson and Dr. Stephan Grupp with the 'Disruptors of the Year' ...

Columnist Mary Shaniqua shares some practical examples of how to support, comfort, and encourage a loved one with sickle cell.

Sickle cell disease is a severe, inherited blood disorder that primarily affects people of African, Mediterranean, Middle Eastern, and Indian descent.Despite its widespread impact, SCD research has ...

The Medical University of South Carolina Health has established the Rena N. Grant Sickle Cell Center to help treat those ...

Scott Turner Department of Housing and Urban Development secretary, announced a new Department of Government Efficiency Task ...

MUSC recieved updatesThe MUSC Board of Trustees received a key program update at the February board meeting on a ...

Deshawn "DJ" Chow is one of just over 100 sickle cell patients who have undergone treatment with new gene therapies. CVS Health CEO David Joyner said private insurers and employer-sponsored health ...

Living with sickle cell disease comes with challenges, such as pain crises that can set a patient back days, weeks, or even months. The mental and physical toll can be immense. Because February is ...

Dr. Thompson and Dr. Grupp are recognized for being in the forefront of innovating gene therapies for patients suffering from sickle cell disease. The gene therapy is specifically designed to ...